Massive venlafaxine overdose resulted in a false positive Abbott AxSYM® urine immunoassay for phencyclidine

被引:21
作者
Bond, GR
Steele, PE
Uges, DRA
机构
[1] Childrens Hosp, Med Ctr, Dept Emergency Med, Drug & Poison Informat Ctr, Cincinnati, OH 45229 USA
[2] Childrens Hosp, Med Ctr, Dept Pathol, Cincinnati, OH 45229 USA
[3] Univ Groningen Hosp, Lab Clin & Forens Toxicol & Drug Anal, Groningen, Netherlands
来源
JOURNAL OF TOXICOLOGY-CLINICAL TOXICOLOGY | 2003年 / 41卷 / 07期
关键词
venlafaxine; phencyclidine; urine drug screen; Abbott AxSYW (R) immunoassay;
D O I
10.1081/CLT-120026525
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
Case report: A 13-yr-old girl overdosed on 48 x 150 mg venlafaxine (Effexor XR(R)). She was taking venlafaxine regularly for depression. Her only other medications included topical Benzamycin and pyridoxine 50 mg daily for acne. The Abbott AxSYM(R) assay was positive only for phencyclidine, but GC/MS did not confirm the presence of phencyclidine. Toxilab(R) identified only one substance, confirmed by GC/MS as venlafaxine. A serum sample obtained 3 h after her ingestion revealed a venlafaxine concentration of 24460 ng/mL and an O-desmethylvenlafaxine concentration of 3930 ng/mL, confirming the massive acute overdose (therapeutic range of venlafaxine and O-desmethylvenlafaxine together is 250-750 ng/mL). Urine spiked with 4.2 mg/mL of venlafaxine and 0.7 mg/mL of O-desmethylvenlafaxine was interpreted as positive with the Abbott AxSYM(R) fluorescent polarized immunoassay for phencyclidine (readout of 28 ng/mL). Conclusion: Venlafaxine may cause a false positive Abbott AxSYM(R) phencyclidine assay when present in very high concentrations. Physicians should be aware of this potential reaction when interpreting urine drug immunoassays.
引用
收藏
页码:999 / 1002
页数:4
相关论文
共 10 条
[1]  
*ABB LAB, 1999, ABB AXSYM SYST PHEN
[2]  
RAINEY PM, 2002, GOLDFRANKS TOXICOLOG, P69
[3]  
Sena SF, 2002, CLIN CHEM, V48, P676
[4]  
Shannon M, 1998, PEDIATR EMERG CARE, V14, P180, DOI 10.1097/00006565-199804000-00023
[5]  
Simone K., 2002, Journal of Toxicology Clinical Toxicology, V40, P657
[6]  
Simone K. L., 2002, Journal of Toxicology Clinical Toxicology, V40, P653
[7]  
SINEGAL M, 2002, COMMUNICATION 0919
[8]   THE PHARMACOKINETICS OF VENLAFAXINE WHEN GIVEN IN A TWICE-DAILY REGIMEN [J].
TROY, SM ;
PARKER, VD ;
FRUNCILLO, RJ ;
CHIANG, ST .
JOURNAL OF CLINICAL PHARMACOLOGY, 1995, 35 (04) :404-409
[9]  
Woo O. F., 1995, Journal of Toxicology Clinical Toxicology, V33, P549
[10]  
YOSHOCK K, 2001, COMMUNICATION 0423